Logo image of JCSE

JE CLEANTECH HOLDINGS LTD (JCSE) Stock Fundamental Analysis

NASDAQ:JCSE - Nasdaq - KYG508752055 - Common Stock - Currency: USD

0.9611  +0.02 (+2.24%)

Fundamental Rating

2

Overall JCSE gets a fundamental rating of 2 out of 10. We evaluated JCSE against 128 industry peers in the Machinery industry. JCSE may be in some trouble as it scores bad on both profitability and health. JCSE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

JCSE had positive earnings in the past year.
JCSE had a positive operating cash flow in the past year.
Of the past 5 years JCSE 4 years were profitable.
Of the past 5 years JCSE 4 years had a positive operating cash flow.
JCSE Yearly Net Income VS EBIT VS OCF VS FCFJCSE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 2M -2M -4M -6M

1.2 Ratios

JCSE has a Return On Assets of 2.43%. This is comparable to the rest of the industry: JCSE outperforms 42.97% of its industry peers.
JCSE has a Return On Equity of 4.85%. This is comparable to the rest of the industry: JCSE outperforms 41.41% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.20%, JCSE is in line with its industry, outperforming 41.41% of the companies in the same industry.
JCSE had an Average Return On Invested Capital over the past 3 years of 3.59%. This is significantly below the industry average of 10.67%.
The last Return On Invested Capital (5.20%) for JCSE is above the 3 year average (3.59%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.43%
ROE 4.85%
ROIC 5.2%
ROA(3y)1.61%
ROA(5y)2.91%
ROE(3y)3.47%
ROE(5y)9.53%
ROIC(3y)3.59%
ROIC(5y)10.51%
JCSE Yearly ROA, ROE, ROICJCSE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 5 10 15 20 25

1.3 Margins

JCSE has a Profit Margin (4.20%) which is in line with its industry peers.
JCSE's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 6.94%, JCSE perfoms like the industry average, outperforming 45.31% of the companies in the same industry.
In the last couple of years the Operating Margin of JCSE has declined.
JCSE has a worse Gross Margin (25.56%) than 60.16% of its industry peers.
In the last couple of years the Gross Margin of JCSE has declined.
Industry RankSector Rank
OM 6.94%
PM (TTM) 4.2%
GM 25.56%
OM growth 3Y-30.23%
OM growth 5YN/A
PM growth 3Y-29.12%
PM growth 5YN/A
GM growth 3Y-4.24%
GM growth 5YN/A
JCSE Yearly Profit, Operating, Gross MarginsJCSE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 5 10 15 20 25

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), JCSE is destroying value.
Compared to 1 year ago, JCSE has about the same amount of shares outstanding.
JCSE has a better debt/assets ratio than last year.
JCSE Yearly Shares OutstandingJCSE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
JCSE Yearly Total Debt VS Total AssetsJCSE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of 1.46, we must say that JCSE is in the distress zone and has some risk of bankruptcy.
JCSE's Altman-Z score of 1.46 is on the low side compared to the rest of the industry. JCSE is outperformed by 72.66% of its industry peers.
The Debt to FCF ratio of JCSE is 88.28, which is on the high side as it means it would take JCSE, 88.28 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of JCSE (88.28) is worse than 70.31% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that JCSE is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.21, JCSE is doing good in the industry, outperforming 68.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 88.28
Altman-Z 1.46
ROIC/WACC0.59
WACC8.88%
JCSE Yearly LT Debt VS Equity VS FCFJCSE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 5M -5M 10M 15M

2.3 Liquidity

JCSE has a Current Ratio of 2.06. This indicates that JCSE is financially healthy and has no problem in meeting its short term obligations.
JCSE has a Current ratio (2.06) which is in line with its industry peers.
JCSE has a Quick Ratio of 1.02. This is a normal value and indicates that JCSE is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of JCSE (1.02) is worse than 65.63% of its industry peers.
Industry RankSector Rank
Current Ratio 2.06
Quick Ratio 1.02
JCSE Yearly Current Assets VS Current LiabilitesJCSE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

0

3. Growth

3.1 Past

The earnings per share for JCSE have decreased strongly by -39.32% in the last year.
Measured over the past years, JCSE shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -33.33% on average per year.
Looking at the last year, JCSE shows a decrease in Revenue. The Revenue has decreased by -1.40% in the last year.
Measured over the past years, JCSE shows a decrease in Revenue. The Revenue has been decreasing by -5.55% on average per year.
EPS 1Y (TTM)-39.32%
EPS 3Y-33.33%
EPS 5YN/A
EPS Q2Q%114.36%
Revenue 1Y (TTM)-1.4%
Revenue growth 3Y-5.55%
Revenue growth 5YN/A
Sales Q2Q%21.87%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JCSE Yearly Revenue VS EstimatesJCSE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 5M 10M 15M 20M

3

4. Valuation

4.1 Price/Earnings Ratio

JCSE is valuated cheaply with a Price/Earnings ratio of 7.39.
Based on the Price/Earnings ratio, JCSE is valued cheaply inside the industry as 91.41% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 28.29, JCSE is valued rather cheaply.
Industry RankSector Rank
PE 7.39
Fwd PE N/A
JCSE Price Earnings VS Forward Price EarningsJCSE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

94.53% of the companies in the same industry are more expensive than JCSE, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of JCSE indicates a slightly more expensive valuation: JCSE is more expensive than 65.63% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 63.18
EV/EBITDA 4.67
JCSE Per share dataJCSE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.72%, JCSE is a good candidate for dividend investing.
In the last 3 months the price of JCSE has falen by -34.40%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 2.12, JCSE pays a better dividend. On top of this JCSE pays more dividend than 99.22% of the companies listed in the same industry.
JCSE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.57.
Industry RankSector Rank
Dividend Yield 9.72%

5.2 History

JCSE is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
JCSE Yearly Dividends per shareJCSE Yearly Dividends per shareYearly Dividends per share 2024 0.02 0.04 0.06 0.08

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
JCSE Yearly Income VS Free CF VS DividendJCSE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 0 2M -2M -4M -6M

JE CLEANTECH HOLDINGS LTD

NASDAQ:JCSE (4/17/2025, 8:00:02 PM)

0.9611

+0.02 (+2.24%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)09-27 2022-09-27/bmo
Earnings (Next)N/A N/A
Inst Owners1.54%
Inst Owner ChangeN/A
Ins Owners5.99%
Ins Owner ChangeN/A
Market Cap4.82M
AnalystsN/A
Price TargetN/A
Short Float %0.18%
Short Ratio0.16
Dividend
Industry RankSector Rank
Dividend Yield 9.72%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 7.39
Fwd PE N/A
P/S 0.32
P/FCF 63.18
P/OCF 34.52
P/B 0.37
P/tB 0.37
EV/EBITDA 4.67
EPS(TTM)0.13
EY13.53%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY1.58%
OCF(TTM)0.03
OCFY2.9%
SpS3.04
BVpS2.63
TBVpS2.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.43%
ROE 4.85%
ROCE 6.29%
ROIC 5.2%
ROICexc 6.66%
ROICexgc 6.66%
OM 6.94%
PM (TTM) 4.2%
GM 25.56%
FCFM 0.5%
ROA(3y)1.61%
ROA(5y)2.91%
ROE(3y)3.47%
ROE(5y)9.53%
ROIC(3y)3.59%
ROIC(5y)10.51%
ROICexc(3y)4.9%
ROICexc(5y)11.89%
ROICexgc(3y)4.9%
ROICexgc(5y)11.89%
ROCE(3y)4.46%
ROCE(5y)12.77%
ROICexcg growth 3Y-41.73%
ROICexcg growth 5YN/A
ROICexc growth 3Y-41.73%
ROICexc growth 5YN/A
OM growth 3Y-30.23%
OM growth 5YN/A
PM growth 3Y-29.12%
PM growth 5YN/A
GM growth 3Y-4.24%
GM growth 5YN/A
F-Score4
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 88.28
Debt/EBITDA 1.64
Cap/Depr 10.02%
Cap/Sales 0.42%
Interest Coverage 2.46
Cash Conversion 8.27%
Profit Quality 11.93%
Current Ratio 2.06
Quick Ratio 1.02
Altman-Z 1.46
F-Score4
WACC8.88%
ROIC/WACC0.59
Cap/Depr(3y)93.98%
Cap/Depr(5y)76.45%
Cap/Sales(3y)3.64%
Cap/Sales(5y)3.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.32%
EPS 3Y-33.33%
EPS 5YN/A
EPS Q2Q%114.36%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.4%
Revenue growth 3Y-5.55%
Revenue growth 5YN/A
Sales Q2Q%21.87%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.18%
EBIT growth 3Y-34.11%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y101.61%
FCF growth 3Y11.93%
FCF growth 5YN/A
OCF growth 1Y103.41%
OCF growth 3Y7.4%
OCF growth 5YN/A